BridgeMD
Tests treatment safety and results for Meniscus Tears
Official title Evaluation of the Performance and Safety of a Single-dose Hyaluronic Acid (Promovia Hydro Balance) in the Treatment of Non-traumatic Degenerative Meniscus Tears
ClinicalTrials.gov ID: NCT07539194
What this study is testing
- What it's testing
- Evaluation of the performance and safety of a single-dose hyaluronic acid (Promovia hydro balance) in the treatment of non-traumatic degenerative meniscus tears
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 35 to 75
You may be able to join if
- \- Age between 35 and 75 years at the time of administration.
- Presence of a symptomatic degenerative meniscus tear, not related to acute trauma, documented by MRI.
- Positive meniscal tests.
- Pain intensity NRS ≥ 4.
- Willingness to participate in physical therapy or light exercise.
You likely can't join if
- \- Patients with traumatic meniscus tears.
- Patients with a meniscal tear requiring surgical treatment (FLAP tear, radial tear, RAMP tear).
- Patients with severe knee osteoarthritis.
- Patients with axial deviation greater than 10°.
- Patients who have undergone meniscal or ligament surgery in the previous 12 months.
- Patients with rheumatic diseases or chondrocalcinosis.
See the full eligibility criteria
- \- Age between 35 and 75 years at the time of administration.
- Presence of a symptomatic degenerative meniscus tear, not related to acute trauma, documented by MRI.
- Positive meniscal tests.
- Pain intensity NRS ≥ 4.
- Willingness to participate in physical therapy or light exercise.
- Informed consent received, understood, and signed by the patient for active participation in the study and for the processing of personal data.
- Ability of the patient to understand the study conditions and to participate for the entire duration of the study.
- \- Patients with traumatic meniscus tears.
- Patients with a meniscal tear requiring surgical treatment (FLAP tear, radial tear, RAMP tear).
- Patients with severe knee osteoarthritis.
- Patients with axial deviation greater than 10°.
- Patients who have undergone meniscal or ligament surgery in the previous 12 months.
- Patients with rheumatic diseases or chondrocalcinosis.
- Patients with signs of possible infection in the affected joint or a skin disease involving the knee (e.g., dermatitis, psoriasis).
- Patients with diabetes.
- Patients with coagulopathies, platelet aggregation disorders, or those receiving oral anticoagulants or antiplatelet drugs.
- Patients receiving intra-articular corticosteroids or hyaluronic acid in the previous 12 months.
- Pregnant or breastfeeding patients.
The study team makes the final eligibility decision.
Where it's taking place
- Milan, MI, Italy
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 35 years to 75 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Milan, MI, Italy. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.